Prevalence of Ethnic Neutropenia and Duffy Null Phenotype in Neonates

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age1-1
SponsorKaplan Medical Center

About this trial

This is a prospective observational study designed to assess the prevalence of the Duffy null phenotype (associated with ethnic neutropenia) in neonates born at Kaplan Medical Center. Blood samples will be collected from umbilical cords (non-invasively) to evaluate Duffy antigen expression. Data on ethnicity, perinatal factors, and routine blood counts at 9-12 months (when available) will also be collected to correlate phenotype with absolute neutrophil count (ANC).

Eligibility criteria

Qualifiers

Neonates born at Kaplan Medical Center between 1.9.2024 and 31.12.2025

Parental informed consent obtained

Umbilical cord blood available for routine testing

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Cord blood

Treatment groups

1,000 Participants
are divided into 1 treatment group

Sponsors and collaborators